InBody Co.Ltd Asset Resilience Ratio
InBody Co.Ltd asset resilience ratio. InBody Co.Ltd (041830) has an Asset Resilience Ratio of 20.98% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 041830 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of InBody Co.Ltd (2011–2024)
Asset resilience ratio of InBody Co.Ltd from 2011 to 2024. This chart shows how InBody Co.Ltd's Asset Resilience Ratio has changed over time. Read 041830 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down InBody Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 041830 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩66.79 Billion | 20.98% |
| Total Liquid Assets | ₩66.79 Billion | 20.98% |
Asset Resilience Insights
- Good Liquidity Position: InBody Co.Ltd maintains a healthy 20.98% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
InBody Co.Ltd Industry Peers by Asset Resilience Ratio
Compare InBody Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Elbit Med Tech
TA:EMTC |
Healthcare Equipment & Supplies | 7.83% |
|
INFINITT Healthcare Co. Ltd
KQ:071200 |
Healthcare Equipment & Supplies | 61.76% |
|
Value Added Technology Co. Ltd
KQ:043150 |
Healthcare Equipment & Supplies | 3.34% |
|
i-SENS Inc
KQ:099190 |
Healthcare Equipment & Supplies | 8.59% |
|
Sewoon Medical Co. Ltd
KQ:100700 |
Healthcare Equipment & Supplies | 11.84% |
|
Meta Biomed Co. Ltd
KQ:059210 |
Healthcare Equipment & Supplies | 11.86% |
|
MEDIANA Co.Ltd
KQ:041920 |
Healthcare Equipment & Supplies | 39.47% |
|
CU Medical Systems Inc
KQ:115480 |
Healthcare Equipment & Supplies | 6.84% |
InBody Co.Ltd Asset Resilience Ratio by Year (2011–2024)
InBody Co.Ltd asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for InBody Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 33.92% | ₩103.72 Billion ≈ $70.29 Million |
₩305.82 Billion ≈ $207.25 Million |
-2.14pp |
| 2023-12-31 | 36.06% | ₩98.97 Billion ≈ $67.07 Million |
₩274.46 Billion ≈ $186.00 Million |
+0.39pp |
| 2022-12-31 | 35.66% | ₩86.55 Billion ≈ $58.65 Million |
₩242.67 Billion ≈ $164.45 Million |
+0.61pp |
| 2021-12-31 | 35.06% | ₩71.43 Billion ≈ $48.41 Million |
₩203.76 Billion ≈ $138.09 Million |
+0.45pp |
| 2020-12-31 | 34.60% | ₩57.49 Billion ≈ $38.96 Million |
₩166.15 Billion ≈ $112.60 Million |
+7.68pp |
| 2019-12-31 | 26.92% | ₩41.70 Billion ≈ $28.26 Million |
₩154.90 Billion ≈ $104.98 Million |
+7.58pp |
| 2018-12-31 | 19.34% | ₩25.47 Billion ≈ $17.26 Million |
₩131.69 Billion ≈ $89.24 Million |
-24.16pp |
| 2017-12-31 | 43.50% | ₩48.74 Billion ≈ $33.03 Million |
₩112.02 Billion ≈ $75.92 Million |
+5.15pp |
| 2016-12-31 | 38.35% | ₩37.22 Billion ≈ $25.22 Million |
₩97.06 Billion ≈ $65.78 Million |
+5.51pp |
| 2015-12-31 | 32.83% | ₩27.10 Billion ≈ $18.36 Million |
₩82.53 Billion ≈ $55.93 Million |
-6.27pp |
| 2014-12-31 | 39.11% | ₩24.70 Billion ≈ $16.74 Million |
₩63.17 Billion ≈ $42.81 Million |
+6.65pp |
| 2013-12-31 | 32.46% | ₩17.42 Billion ≈ $11.81 Million |
₩53.67 Billion ≈ $36.37 Million |
-8.55pp |
| 2012-12-31 | 41.01% | ₩19.75 Billion ≈ $13.38 Million |
₩48.16 Billion ≈ $32.64 Million |
-1.29pp |
| 2011-12-31 | 42.30% | ₩18.55 Billion ≈ $12.57 Million |
₩43.85 Billion ≈ $29.72 Million |
-- |
About InBody Co.Ltd
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was foun… Read more